Literature DB >> 9267992

The beta cell glucokinase promoter variant is an unlikely risk factor for diabetes mellitus. Diabetes Incidence Study in Sweden (DISS).

K Lotfi1, G Sund, R Lowe, J Graham, M Landin-Olsson, I Kockum, S Deeb, A Lernmark.   

Abstract

Glucokinase plays an important role in the regulation of insulin secretion and is therefore an attractive candidate gene for both insulin dependent (IDDM) and non-insulin-dependent (NIDDM) diabetes mellitus. A single G-A nucleotide polymorphism at the -30 position of the beta-cell specific promoter region of the glucokinase gene was previously associated with reduced beta-cell function. In the present study we analysed 268 consecutive newly diagnosed Swedish patients classified with either IDDM (n = 205), NIDDM (n = 31) or unclassifiable (n = 32) diabetes between the ages of 15 and 35 years along with a group of 158 age- and sex-matched control subjects. The beta-cell promoter region was amplified by the polymerase chain reaction and the G-A variant identified by single strand conformational polymorphism. There was no significant difference in allele frequencies of G and A between any of the subject groups and likewise, no significant difference in the frequencies of the G/G, G/A, or A/A genotypes. Eight subjects were homozygous for the less common A allele, five had IDDM and three were control subjects. Our results suggest that the -30 beta-cell glucokinase promoter variant is not associated with IDDM.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9267992     DOI: 10.1007/s001250050774

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  2 in total

1.  Association of GCKR rs780094, alone or in combination with GCK rs1799884, with type 2 diabetes and related traits in a Han Chinese population.

Authors:  Q Qi; Y Wu; H Li; R J F Loos; F B Hu; L Sun; L Lu; A Pan; C Liu; H Wu; L Chen; Z Yu; X Lin
Journal:  Diabetologia       Date:  2009-02-25       Impact factor: 10.122

2.  Genetic polymorphism of glucokinase on the risk of type 2 diabetes and impaired glucose regulation: evidence based on 298,468 subjects.

Authors:  Da Fu; Xianling Cong; Yushui Ma; Haidong Cai; Mingxiang Cai; Dan Li; Mingli Lv; Xueyu Yuan; Yinghui Huang; Zhongwei Lv
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.